JP2010512220A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010512220A5 JP2010512220A5 JP2009540967A JP2009540967A JP2010512220A5 JP 2010512220 A5 JP2010512220 A5 JP 2010512220A5 JP 2009540967 A JP2009540967 A JP 2009540967A JP 2009540967 A JP2009540967 A JP 2009540967A JP 2010512220 A5 JP2010512220 A5 JP 2010512220A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- drugs
- chitosan
- composition according
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 42
- 229920001661 Chitosan Polymers 0.000 claims 25
- 229940079593 drug Drugs 0.000 claims 23
- 239000003814 drug Substances 0.000 claims 23
- 238000012377 drug delivery Methods 0.000 claims 9
- 210000004027 cell Anatomy 0.000 claims 8
- 239000003795 chemical substances by application Substances 0.000 claims 8
- 239000000243 solution Substances 0.000 claims 7
- 238000000034 method Methods 0.000 claims 6
- 239000000499 gel Substances 0.000 claims 5
- 230000001315 anti-hyperlipaemic effect Effects 0.000 claims 4
- 150000004676 glycans Chemical class 0.000 claims 4
- 229920000642 polymer Polymers 0.000 claims 4
- 229920001282 polysaccharide Polymers 0.000 claims 4
- 239000005017 polysaccharide Substances 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 238000013268 sustained release Methods 0.000 claims 4
- 239000012730 sustained-release form Substances 0.000 claims 4
- 210000001519 tissue Anatomy 0.000 claims 4
- 201000004624 Dermatitis Diseases 0.000 claims 3
- 241001674048 Phthiraptera Species 0.000 claims 3
- 230000000895 acaricidal effect Effects 0.000 claims 3
- 239000000642 acaricide Substances 0.000 claims 3
- 230000000507 anthelmentic effect Effects 0.000 claims 3
- 230000003255 anti-acne Effects 0.000 claims 3
- 230000003712 anti-aging effect Effects 0.000 claims 3
- 230000003501 anti-edematous effect Effects 0.000 claims 3
- 230000000843 anti-fungal effect Effects 0.000 claims 3
- -1 anti-hyperlipidemic Substances 0.000 claims 3
- 230000003110 anti-inflammatory effect Effects 0.000 claims 3
- 230000000845 anti-microbial effect Effects 0.000 claims 3
- 230000002579 anti-swelling effect Effects 0.000 claims 3
- 230000000656 anti-yeast Effects 0.000 claims 3
- 239000000935 antidepressant agent Substances 0.000 claims 3
- 239000003963 antioxidant agent Substances 0.000 claims 3
- 239000003908 antipruritic agent Substances 0.000 claims 3
- 239000002131 composite material Substances 0.000 claims 3
- 239000003246 corticosteroid Substances 0.000 claims 3
- 239000003995 emulsifying agent Substances 0.000 claims 3
- 230000000855 fungicidal effect Effects 0.000 claims 3
- 239000000417 fungicide Substances 0.000 claims 3
- 239000005556 hormone Substances 0.000 claims 3
- 229940088597 hormone Drugs 0.000 claims 3
- 150000001261 hydroxy acids Chemical class 0.000 claims 3
- 150000003951 lactams Chemical class 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000002105 nanoparticle Substances 0.000 claims 3
- 238000002360 preparation method Methods 0.000 claims 3
- 239000000583 progesterone congener Substances 0.000 claims 3
- 201000004700 rosacea Diseases 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- 238000011282 treatment Methods 0.000 claims 3
- 229940124549 vasodilator Drugs 0.000 claims 3
- 239000003071 vasodilator agent Substances 0.000 claims 3
- 206010063409 Acarodermatitis Diseases 0.000 claims 2
- 229920002683 Glycosaminoglycan Polymers 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 241000447727 Scabies Species 0.000 claims 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims 2
- 230000021736 acetylation Effects 0.000 claims 2
- 238000006640 acetylation reaction Methods 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 230000003444 anaesthetic effect Effects 0.000 claims 2
- 230000000202 analgesic effect Effects 0.000 claims 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 2
- 230000001430 anti-depressive effect Effects 0.000 claims 2
- 230000001387 anti-histamine Effects 0.000 claims 2
- 229940124599 anti-inflammatory drug Drugs 0.000 claims 2
- 230000001139 anti-pruritic effect Effects 0.000 claims 2
- 229940005513 antidepressants Drugs 0.000 claims 2
- 229940121375 antifungal agent Drugs 0.000 claims 2
- 239000000739 antihistaminic agent Substances 0.000 claims 2
- 239000004599 antimicrobial Substances 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- 230000003078 antioxidant effect Effects 0.000 claims 2
- 239000003443 antiviral agent Substances 0.000 claims 2
- 230000003115 biocidal effect Effects 0.000 claims 2
- 210000000988 bone and bone Anatomy 0.000 claims 2
- 239000002327 cardiovascular agent Substances 0.000 claims 2
- 229940125692 cardiovascular agent Drugs 0.000 claims 2
- 229940127089 cytotoxic agent Drugs 0.000 claims 2
- 230000006196 deacetylation Effects 0.000 claims 2
- 238000003381 deacetylation reaction Methods 0.000 claims 2
- 210000002950 fibroblast Anatomy 0.000 claims 2
- 239000000017 hydrogel Substances 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 239000002917 insecticide Substances 0.000 claims 2
- 239000002085 irritant Substances 0.000 claims 2
- 239000003410 keratolytic agent Substances 0.000 claims 2
- 239000002207 metabolite Substances 0.000 claims 2
- 208000005687 scabies Diseases 0.000 claims 2
- 210000004872 soft tissue Anatomy 0.000 claims 2
- 230000003637 steroidlike Effects 0.000 claims 2
- 210000002435 tendon Anatomy 0.000 claims 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims 1
- 239000005541 ACE inhibitor Substances 0.000 claims 1
- 241001474374 Blennius Species 0.000 claims 1
- 229920001287 Chondroitin sulfate Polymers 0.000 claims 1
- 102000001554 Hemoglobins Human genes 0.000 claims 1
- 108010054147 Hemoglobins Proteins 0.000 claims 1
- 229920000288 Keratan sulfate Polymers 0.000 claims 1
- 229940124091 Keratolytic Drugs 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims 1
- 208000024288 Rotator Cuff injury Diseases 0.000 claims 1
- 206010039227 Rotator cuff syndrome Diseases 0.000 claims 1
- 208000021945 Tendon injury Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 229940035676 analgesics Drugs 0.000 claims 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 claims 1
- 210000004102 animal cell Anatomy 0.000 claims 1
- 239000000730 antalgic agent Substances 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000002421 anti-septic effect Effects 0.000 claims 1
- 230000000840 anti-viral effect Effects 0.000 claims 1
- 229940124350 antibacterial drug Drugs 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 239000003529 anticholesteremic agent Substances 0.000 claims 1
- 229940127226 anticholesterol agent Drugs 0.000 claims 1
- 229940124623 antihistamine drug Drugs 0.000 claims 1
- 229940030999 antipsoriatics Drugs 0.000 claims 1
- 229940064004 antiseptic throat preparations Drugs 0.000 claims 1
- 239000000560 biocompatible material Substances 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 210000000845 cartilage Anatomy 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 claims 1
- 230000010261 cell growth Effects 0.000 claims 1
- 230000000973 chemotherapeutic effect Effects 0.000 claims 1
- 210000001612 chondrocyte Anatomy 0.000 claims 1
- 229940059329 chondroitin sulfate Drugs 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 238000006731 degradation reaction Methods 0.000 claims 1
- 239000000645 desinfectant Substances 0.000 claims 1
- 229960000633 dextran sulfate Drugs 0.000 claims 1
- 230000002526 effect on cardiovascular system Effects 0.000 claims 1
- 230000002500 effect on skin Effects 0.000 claims 1
- 238000013265 extended release Methods 0.000 claims 1
- 239000002778 food additive Substances 0.000 claims 1
- 235000013373 food additive Nutrition 0.000 claims 1
- 230000037406 food intake Effects 0.000 claims 1
- 210000004211 gastric acid Anatomy 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 230000012010 growth Effects 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 230000036571 hydration Effects 0.000 claims 1
- 238000006703 hydration reaction Methods 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 claims 1
- 210000002510 keratinocyte Anatomy 0.000 claims 1
- 230000001530 keratinolytic effect Effects 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 210000003041 ligament Anatomy 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims 1
- 238000000694 mesotherapy Methods 0.000 claims 1
- 210000000651 myofibroblast Anatomy 0.000 claims 1
- 229950006780 n-acetylglucosamine Drugs 0.000 claims 1
- 239000004081 narcotic agent Substances 0.000 claims 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 1
- 239000000575 pesticide Substances 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 239000000021 stimulant Substances 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 230000017423 tissue regeneration Effects 0.000 claims 1
- 238000002604 ultrasonography Methods 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87393106P | 2006-12-11 | 2006-12-11 | |
| US60/873,931 | 2006-12-11 | ||
| US92458207P | 2007-05-21 | 2007-05-21 | |
| US60/924,582 | 2007-05-21 | ||
| PCT/IL2007/001530 WO2008072230A1 (en) | 2006-12-11 | 2007-12-11 | Novel injectable chitosan mixtures forming hydrogels |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010512220A JP2010512220A (ja) | 2010-04-22 |
| JP2010512220A5 true JP2010512220A5 (enExample) | 2011-02-10 |
| JP5539727B2 JP5539727B2 (ja) | 2014-07-02 |
Family
ID=39125101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009540967A Expired - Fee Related JP5539727B2 (ja) | 2006-12-11 | 2007-12-11 | ヒドロゲルを形成する新規な注入可能なキトサン混合物 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2121026B1 (enExample) |
| JP (1) | JP5539727B2 (enExample) |
| AU (1) | AU2007331071A1 (enExample) |
| CA (1) | CA2672495C (enExample) |
| WO (1) | WO2008072230A1 (enExample) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
| US9034348B2 (en) | 2006-12-11 | 2015-05-19 | Chi2Gel Ltd. | Injectable chitosan mixtures forming hydrogels |
| HUE042931T2 (hu) | 2007-11-16 | 2019-07-29 | Aclaris Therapeutics Inc | Kompozíciók és eljárások purpura kezelésére |
| US8394782B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
| JP5746617B2 (ja) * | 2008-06-11 | 2015-07-08 | チ２ジェル リミテッドＣｈｉ２Ｇｅｌ Ｌｔｄ． | キトサン混合物を形成する注入可能なヒドロゲル |
| US8450475B2 (en) | 2008-08-04 | 2013-05-28 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
| AU2009288118B2 (en) | 2008-09-02 | 2014-12-11 | Allergan, Inc. | Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
| CA2771365A1 (en) * | 2009-09-01 | 2011-03-10 | Medovent Gmbh | Chitosan tissue dressing |
| AU2010289417B2 (en) | 2009-09-02 | 2015-08-13 | Synedgen, Inc. | Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds |
| US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
| US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
| DE102010009475B4 (de) * | 2010-02-26 | 2011-11-24 | F. Holzer Gmbh | Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates |
| CA2792729C (en) | 2010-03-12 | 2016-06-28 | Allergan Industrie, Sas | Fluid compositions for improving skin conditions |
| HUE030138T2 (en) | 2010-03-22 | 2017-04-28 | Allergan Inc | Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
| US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
| US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US11311644B2 (en) | 2010-09-01 | 2022-04-26 | Medoderm Gmbh | Antimicrobial and/or epithelial cell growth stimulating substance and composition and tissue dressing material |
| CN102727925B (zh) * | 2011-04-02 | 2014-09-17 | 佛山市优特医疗科技有限公司 | 酰化壳聚糖伤口敷料、其制备方法及其应用 |
| US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
| US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
| US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
| KR102154944B1 (ko) | 2011-06-03 | 2020-09-11 | 알러간 인더스트리 에스에이에스 | 항산화제를 포함하는 피부 충전제 조성물 |
| US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
| US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
| FR2983070B1 (fr) | 2011-11-30 | 2014-04-25 | Cytosial Biomedic | Solution aqueuse homogene de chitosane injectable |
| KR101502579B1 (ko) * | 2012-10-31 | 2015-03-16 | 충남대학교산학협력단 | 소수성 치환기를 갖는 글리콜 키토산 유도체, 이의 제조방법 및 용도 |
| WO2014117146A1 (en) * | 2013-01-28 | 2014-07-31 | Rutgers, The State University Of New Jersey | Growth matrices for stem cell propagation in vitro and in tissue regeneration |
| CN103983593A (zh) * | 2013-11-20 | 2014-08-13 | 中国科学院海洋研究所 | 一种测定壳聚糖与壳寡糖混合物的脱乙酰度的方法 |
| WO2015186101A1 (en) * | 2014-06-05 | 2015-12-10 | University Of The Witwatersrand, Johannesburg | Wound dressing |
| EP4420518A3 (en) | 2014-09-11 | 2024-11-20 | Synedgen, Inc. | Compositions and methods of use thereof |
| US10722444B2 (en) | 2014-09-30 | 2020-07-28 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
| WO2016128783A1 (en) | 2015-02-09 | 2016-08-18 | Allergan Industrie Sas | Compositions and methods for improving skin appearance |
| PL3256179T3 (pl) | 2015-02-13 | 2020-05-18 | Allergan Industrie, Sas | Implanty do kształtowania, uwydatniania lub korygowania cech twarzy takich jak broda |
| FR3035327B1 (fr) | 2015-04-23 | 2021-07-02 | Cytosial Biomedic | Solution aqueuse homogene de chitosane ou derive de chitosane injectable presentant un ph proche du ph physiologique |
| US10531957B2 (en) | 2015-05-21 | 2020-01-14 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
| JP6864001B2 (ja) * | 2015-11-03 | 2021-04-21 | ゾエティス・サービシーズ・エルエルシー | ゾル−ゲルポリマー組成物及びそれらの使用 |
| CN106046397A (zh) * | 2016-06-28 | 2016-10-26 | 深圳市阳光之路生物材料科技有限公司 | 一种关节润滑材料及其制备方法 |
| US10576099B2 (en) | 2016-10-21 | 2020-03-03 | Covidien Lp | Injectable scaffold for treatment of intracranial aneurysms and related technology |
| EP3972562B1 (en) * | 2019-05-22 | 2025-09-03 | Università Degli Studi Di Torino | Medical device comprising a chitosan-based support structure |
| CN114630627A (zh) | 2019-11-04 | 2022-06-14 | 柯惠有限合伙公司 | 用于治疗颅内动脉瘤的装置、系统和方法 |
| WO2022198208A1 (en) | 2021-03-16 | 2022-09-22 | Covidien Lp | Injectable biopolymer compositions and associated systems and methods |
| CN114214838B (zh) * | 2021-12-13 | 2023-11-07 | 宜兴市新立织造有限公司 | 一种蚕丝/凝胶多向纤维夹芯半月板及其制备方法 |
| CN114773630B (zh) * | 2022-05-24 | 2024-06-04 | 湖北工业大学 | 一种光热杀菌的粘附性水凝胶及其制备方法与应用 |
| US12232944B2 (en) | 2022-08-26 | 2025-02-25 | Checkpoint Surgical, Inc. | Chitosan tubular member and method of producing |
| CN116173291B (zh) * | 2023-03-08 | 2025-04-22 | 重庆医科大学附属第二医院 | 一种壳聚糖重组人源化胶原蛋白凝胶及其制备方法与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10309287A (ja) * | 1997-05-12 | 1998-11-24 | Matsumoto Shika Univ | 骨補填材、及びその製造方法 |
| CA2212300A1 (en) * | 1997-08-04 | 1999-02-04 | Abdellatif Chenite | In vitro or in vivo gelfying chitosan and therapeutic uses thereof |
| WO2001010421A1 (en) * | 1999-08-06 | 2001-02-15 | Board Of Regents, The University Of Texas System | Drug releasing biodegradable fiber implant |
| NO20015986D0 (no) * | 2001-08-02 | 2001-12-06 | Einar J Mustaparta | Produktet chitosan, samt fremstillingsmetode og anvendelse av chitosan |
| GB0302741D0 (en) * | 2003-02-06 | 2003-03-12 | Advanced Biopolymers As | Use |
| GB0302738D0 (en) * | 2003-02-06 | 2003-03-12 | Advanced Biopolymers As | Composition |
| CA2589139A1 (en) * | 2004-12-20 | 2006-06-29 | Carbgraft Ab | Chitosan compositions |
-
2007
- 2007-12-11 EP EP07849557.9A patent/EP2121026B1/en not_active Not-in-force
- 2007-12-11 JP JP2009540967A patent/JP5539727B2/ja not_active Expired - Fee Related
- 2007-12-11 AU AU2007331071A patent/AU2007331071A1/en not_active Abandoned
- 2007-12-11 WO PCT/IL2007/001530 patent/WO2008072230A1/en not_active Ceased
- 2007-12-11 CA CA2672495A patent/CA2672495C/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010512220A5 (enExample) | ||
| Deng et al. | A review of current advancements for wound healing: Biomaterial applications and medical devices | |
| Divyashri et al. | Applications of hydrogel‐based delivery systems in wound care and treatment: an up‐to‐date review | |
| US11590259B2 (en) | Composition and kits for pseudoplastic microgel matrices | |
| Zhu et al. | Injectable thermo-sensitive and wide-crack self-healing hydrogel loaded with antibacterial anti-inflammatory dipotassium glycyrrhizate for full-thickness skin wound repair | |
| JP5539727B2 (ja) | ヒドロゲルを形成する新規な注入可能なキトサン混合物 | |
| JP7263459B2 (ja) | 癒着予防のためのハイドロゲル膜 | |
| JP2018511622A5 (enExample) | ||
| Ghomi et al. | Innovations in drug delivery for chronic wound healing | |
| CN114452436B (zh) | 一种胶原基可注射自修复水凝胶及其制备方法 | |
| CN115025385A (zh) | 一种差速释药的微针贴片及其制备方法和应用 | |
| Yue et al. | A bacteria-resistant and self-healing spray dressing based on lyotropic liquid crystals to treat infected post-operative wounds | |
| Zamani et al. | Natural and synthetic polymers in burn wound healing | |
| Zhao et al. | Silver nanoparticles incorporated chitosan hydrogel as a potential dressing material for diabetic wound healing in nursing care | |
| Fletes-Vargas et al. | Natural hydrogels as wound dressing for skin wound-healing applications | |
| CN108404207A (zh) | 温敏壳聚糖水凝胶细胞因子复合支架的制备方法 | |
| CN111991417A (zh) | 一种具有生理响应性的次氯酸凝胶及其在皮肤创面中的应用 | |
| WO2021169075A1 (zh) | 一种集可注射与抗菌于一体的双功能水凝胶及其制备方法和用途 | |
| Bhoopathy et al. | A comprehensive review on natural therapeutics for Wound Treatment | |
| CN101496795A (zh) | 可生物降解复合药物控制释放膜及其制备工艺 | |
| Quadir et al. | Bioresorbable polymers for wound healing | |
| Rajwade et al. | Wound treatment using nanomaterials | |
| HK1208360A1 (en) | Wound healing composition and uses thereof | |
| CN118697697B (zh) | 一种脂质体封装的长效罗哌卡因缓释系统 | |
| WO2024152133A1 (es) | Composición y método para la limpieza y el desbridamiento de heridas y/o úlceras cutáneas |